A Preclinical Evaluation of Antimycin A as a Potential Antilung Cancer Stem Cell Agent

Drug resistance and tumor recurrence are major obstacles in treating lung cancer patients. Accumulating evidence considers lung cancer stem cells (CSCs) as the major contributor to these clinical challenges. Agents that can target lung CSCs could potentially provide a more effective treatment than t...

Full description

Saved in:
Bibliographic Details
Main Authors: Yeh, Chi-Tai, Su, Chun-Li, Huang, Chi-Ying F., Lin, Justin Kung-Yi, Lee, Wei-Hwa, Chang, Peter M.-H., Kuo, Yu-Lun, Liu, Yu-Wen, Wang, Liang-Shun, Wu, Chih-Hsiung, Shieh, Yi-Shing, Jan, Yi-Hua, Chuang, Yung-Jen, Hsiao, Michael, Wu, Alexander T. H.
Format: Artigo
Language:Inglês
Published: Hindawi Publishing Corporation 2013
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3693105/
https://ncbi.nlm.nih.gov/pubmed/23840269
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2013/910451
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items